Summary Basis of Decision (SBD) Documents: Drugs
The SBD documents explain why Health Canada authorized certain drugs for sale in Canada. The documents include regulatory, safety, effectiveness and quality (chemistry and manufacturing) considerations.
SBDs are published for New Drug Submissions that contain a new active substance(s) that were authorized after January 1, 2005. Health Canada will draft Phase II SBDs for all eligible drugs authorized as of September 1, 2012. Eligible products authorized before September 1, 2012, but on or after January 1, 2005, will have SBDs in the Phase I format.
The SBDs are organized alphabetically by product name. Use the following index, or see the list of SBDs for drugs below.
Reader's Guide
For an explanation of the information available in each section of a Phase I SBD, consult the Phase I Reader's Guide.
For an explanation of the information available in each section of a Phase II SBD, consult the Phase II Reader's Guide.
Other Resources
For up to date information on a particular product, readers should refer to the most recent Product Monograph, available on the searchable Drug Product Database.
For information related to Warnings, Recalls and Alerts, go to the MedEffect Canada web page.
Readers should refer to the
Food and Drugs Act and/or the
Food and Drug Regulations for more information about the regulation of drugs.
Readers may also wish to consult the Health Canada website for other policies and guidance documents related to drugs and drug submissions. In particular, readers may wish to refer to the Management of Drug Submissions Guidance.
Summary Basis of Decision Documents: Drugs
A
ABILIFY
ACTEMRA
- Notice of Decision [2010-05-25]
- Summary Basis of Decision [2010-10-04]
ADCETRIS
AFINITOR
ALOXI
ALREX
ALTARGO
ALVESCO
APIDRA
- Notice of Decision [2007-01-05]
- Summary Basis of Decision [2007-07-12]
APTIVUS
AREPANRIXTM H1N1
- Notice of Decision [2009-10-21]
- Summary Basis of Decision [2010-05-11]
ARZERRA
AREPANRIX H5N1
ATRIANCE
AVAMYS
AVASTIN
AZILECT
B
BANZEL
BARACLUDE
BENLYSTA
- Notice of Decision [2011-08-30]
- Summary Basis of Decision [2011-12-15]
BERINERT
- Notice of Decision [2010-07-06]
- Summary Basis of Decision [2011-01-06]
BESIVANCE
BEXXAR
BRILINTA
BYETTA
BYSTOLIC
C
CAMPRAL
CANTRACE
- Notice of Decision [2006-12-13]
- Summary Basis of Decision [2008-01-28]
CAPRELSA
CATENA
CAYSTON
CELSENTRI
CERVARIX
- Notice of Decision [2010-09-02]
- Summary Basis of Decision [2010-10-26]
CHAMPIX
CIMZIA
- Notice of Decision [2009-09-24]
- Summary Basis of Decision [2010-03-11]
CIVANEX
CLEVIPREX
CLOLAR
COLESEVELAM HYDROCHLORIDE (LODALIS)
COVERSYL
CUBICIN
CYMBALTA
D
DAXAS
DEXILANT
DIACOMIT
DIFICID
DORIBAX
E
EDARBI
EDURANT
EFFIENT
EFRACEA
ELAPRASE
ELIQUIS
ELOXATIN
EMEND
EMEND IV
EMTRIVA
ENABLEX
ERAXIS
ERBITUX
ESBRIET
EXELON PATCH
EXJADE
- Notice of Decision [2007-01-17]
- Summary Basis of Decision [2007-11-27]
F
FAMPYRA
FERAHEME
FINACEA
FIRMAGON
FLUMIST
- Notice of Decision [2010-08-26]
- Summary Basis of Decision [2011-01-10]
FOSRENOL
FYCOMPA
G
GARDASIL
GILENYA
H
HALAVEN
I
ILARIS
- Notice of Decision [2010-04-09]
- Summary Basis of Decision [2010-07-29]
INCIVEK
INFLUENZA A (H1N1) 2009 PANDEMIC MONOVALENT VACCINE (WITHOUT ADJUVANT)
- Notice of Decision [2009-11-12]
INLYTA
INOMAX
INSPRA
INTELENCE
INVEGA
INVEGA SUSTENNA
ISENTRESS
IXIARO
- Notice of Decision [2009-12-02]
- Summary Basis of Decision [2010-07-20]
J
JAKAVI
JANUVIA
JEVTANA
K
KALYDECO
KEPIVANCE
KUVAN
L
LATUDA
LEUKOSCAN
LEVEMIR
LODALIS
LUCENTIS
- Notice of Decision [2007-07-30]
- Summary Basis of Decision [2007-12-21]
LUVERIS
LYRICA
M
MABCAMPATH
- Notice of Decision [2006-08-11]
- Summary Basis of Decision [2007-05-29]
MACUGEN
MENVEO
- Notice of Decision [2010-06-23]
- Summary Basis of Decision [2010-10-29]
METVIX
- Notice of Decision [2009-03-17]
- Summary Basis of Decision [2009-07-17]
MIRCERA
- Notice of Decision [2008-07-03]
- Summary Basis of Decision [2009-01-19]
MOZOBIL
MULTAQ
MYCAMINE
MYOZYME
- Notice of Decision [2006-12-06]
- Summary Basis of Decision [2007-07-30]
MYRBETRIQ
N
NATRECOR
- Notice of Decision [2008-05-14]
- Summary Basis of Decision [2007-11-08]
NEVANAC
NEXAVAR
NIMENRIX
NPLATE
- Notice of Decision [2009-03-30]
- Summary Basis of Decision for NPLATE [2009-07-21]
NUCYNTA CR
O
OLMETEC
OMNITROPE
- Notice of Decision [2009-05-15]
- Summary Basis of Decision [2009-09-14]
ONBREZ BREEZHALER
ONGLYZA
ORENCIA
- Notice of Decision [2007-01-08]
- Summary Basis of Decision [2007-05-07]
OXYNEO
P
PANTOLOC M
PICATO
POSANOL
POTIGA
PRADAX
PRECEDEX
PREVNAR 13
- Notice of Decision [2010-01-30]
- Summary Basis of Decision [2010-11-15]
PREXIGE
PREZISTA
PRIMOVIST
PRISTIQ
PROCHYMAL
PROLIA
- Notice of Decision [2010-10-14]
- Summary Basis of Decision [2011-01-17]
R
RAPAFLO
RAPTIVA
- Notice of Decision [2006-08-02]
- Summary Basis of Decision [2007-05-15]
RASILEZ
RECOTHROM
- Notice of Decision [2010-02-10]
- Summary Basis of Decision [2010-08-30]
RELISTOR
REMOVAB
RESOTRAN
REVLIMID
REVOLADE
ROTARIX
- Notice of Decision [2008-01-04]
- Summary Basis of Decision [2008-07-23]
ROTATEQ
- Notice of Decision [2006-12-04]
- Summary Basis of Decision [2007-06-04]
RUBY-FILL
S
SAMSCA
SAPHRIS
SEBIVO
SIMPONI
- Notice of Decision [2009-05-21]
- Summary Basis of Decision [2009-09-02]
SOLIRIS
- Notice of Decision [2009-02-27]
- Summary Basis of Decision [2009-07-22]
SOMATULINE AUTOGEL
SOMAVERT
- Notice of Decision [2006-06-07]
- Summary Basis of Decision [2006-11-06]
SPRYCEL
STELARA
- Notice of Decision [2009-01-29]
- Summary Basis of Decision [2009-05-27]
STIVARGA
STRIBILD
SUTENT
SWISH SILVER SUPREME
SYNFLORIX
- Notice of Decision [2009-02-13]
- Summary Basis of Decision [2009-06-16]
T
TARCEVA
TASIGNA
TECFIDERA
THELIN
TOCTINO
TORISEL
TOVIAZ
TRAJENTA
TRAMACET
TREANDA
TRETTEN
TROSEC
TYKERB
TYGACIL
TYSABRI
- Notice of Decision [2007-04-19]
- Summary Basis of Decision [2007-10-05]
U
ULORIC
V
VANTAS
VASOVIST
VECTIBIX
- Notice of Decision [2008-06-25]
- Summary Basis of Decision [2008-12-18]
VELCADE
VESICARE
VIBATIV
VICTOZA
- Notice of Decision [2010-06-17]
- Summary Basis of Decision [2010-10-26]
VICTRELIS
VIDAZA
VIMPAT
VISANNE
VOLIBRIS
VOLTAREN
VOTRIENT
VPRIV
- Notice of Decision [2010-11-12]
- Summary Basis of Decision [2011-02-25]
VYVANSE
X
XALKORI
XARELTO
XIAFLEX
XYREM
Y
YERVOY
YONDELIS
Z
ZEFTERA
ZELBORAF
ZELDOX
ZEMPLAR
ZEVALIN
ZOLINZA
ZYTIGA